Results 91 to 100 of about 20,653 (256)

Factors Influencing Trust in Advanced Driver Assistance Systems for Current Users. [PDF]

open access: yesProc Hum Factors Ergon Soc Annu Meet, 2023
DeGuzman CA, Donmez B.
europepmc   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Taxonomy, Open Challenges, Motivations, and Recommendations in Driver Behavior Recognition: A Systematic Review

open access: yesIraqi Journal for Computer Science and Mathematics
 Driver behavior has a major role in many of the unpleasant things that happen when driving, such as crashes or accidents, heavy traffic, abrupt braking, and acceleration and deceleration.
ziadoon al-qaysi
doaj   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Quantum Computing for Advanced Driver Assistance Systems and Autonomous Vehicles: A Review

open access: yesIEEE Access
Advanced Driver Assistance System (ADAS) has become an essential feature in vehicles, and it is leading to the evolution of autonomous vehicles. But the technologies to implement ADAS suffer from certain inherent limitations, such as latency rate ...
Avantika Rattan   +2 more
doaj   +1 more source

Advanced Driver Assist System for Automobiles

open access: yesINTERANTIONAL JOURNAL OF SCIENTIFIC RESEARCH IN ENGINEERING AND MANAGEMENT
A group of technologies known as advanced driver assistance systems (ADAS) aid in keeping drivers safe and preventing collisions. These systems monitor the area surrounding the car using a range of sensors, including cameras, radar, and lidar, and if required, send out alerts or make necessary corrections.
Dr Rekha M N   +4 more
openaire   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy